Compound Detail
CHEMBL515387
GOSOGLIPTIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL515387 |
| Name | GOSOGLIPTIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | QWEWGXUTRTXFRF-KBPBESRZSA-N |
6
Targets
9
Activities
1
Assay Types
29
PK Parameters
20
Publications
6
Known Names
2
Indications
1
Mechanisms
Molecular Properties
366.4
MW (Da)
0.20
ALogP
6
HBA
1
HBD
64.6
PSA (Ų)
0.82
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2016 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dipeptidyl peptidase IV inhibitor | INHIBITOR | Dipeptidyl peptidase 4 | ✓ | ✓ |
Indications
Diabetes Mellitus, Type 2 Renal Insufficiency, Chronic
Activity Summary
IC50 9 meas. best 7.95
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dipeptidyl peptidase 4 CHEMBL284 | IC50 | 7.95 | 7.91 | 11.3 | 3 |
| Dipeptidyl peptidase 4 CHEMBL4653 | IC50 | 7.89 | 7.89 | 12.8 | 1 |
| Dipeptidyl peptidase 2 CHEMBL3976 | IC50 | 5.48 | 5.48 | 3300.0 | 1 |
| Dipeptidyl peptidase 9 CHEMBL4793 | IC50 | 5.22 | 5.22 | 5980.0 | 1 |
| Dipeptidyl peptidase 8 CHEMBL4657 | IC50 | 5.16 | 5.16 | 7000.0 | 1 |
| Prolyl endopeptidase FAP CHEMBL4683 | IC50 | 4.99 | 4.99 | 10300.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 843.0 | ng.hr.mL-1 | Macaca fascicularis |
| AUC | 7162.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 2398.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2560.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 2660.0 | ng.hr.mL-1 | Homo sapiens |
| CL | 3.7 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 7.6 | mL.min-1.kg-1 | Macaca fascicularis |
| CL | 38.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 7.0 | mg/ml/g | Homo sapiens |
| CL | 7.1 | mg/ml/g | Homo sapiens |
| Cmax | 1410.95 | nM | Macaca fascicularis |
| Cmax | 3837.13 | nM | Rattus norvegicus |
| Cmax | 4164.62 | nM | Canis lupus familiaris |
| Cmax | 658.53 | nM | Homo sapiens |
| F | 95.0 | % | Canis lupus familiaris |
| F | 71.0 | % | Macaca fascicularis |
| F | 109.0 | % | Rattus norvegicus |
| Fu | 0.8 | - | Rattus norvegicus |
| Fu | 0.8 | - | Canis lupus familiaris |
| Fu | 0.8 | - | Macaca mulatta |
| Fu | 0.8 | - | Homo sapiens |
| T1/2 | 2.5 | hr | Rattus norvegicus |
| T1/2 | 15.1 | hr | Homo sapiens |
| T1/2 | 7.6 | hr | Macaca fascicularis |
| T1/2 | 7.6 | hr | Canis lupus familiaris |
| T1/2 | 63.5 | hr | Homo sapiens |
| T1/2 | 63.5 | hr | Homo sapiens |
| Tmax | 0.5 | hr | Homo sapiens |
| Tmax | 1.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Dipeptidyl peptidase 4 | IC50 | = | 11.3 | nM | 7.95 | Inhibition of human plasma DPP4 | 19275964 |
| Dipeptidyl peptidase 4 | IC50 | = | 12.9 | nM | 7.89 | Inhibition of human recombinant DPP4 | 19275964 |
| Dipeptidyl peptidase 4 | IC50 | = | 12.8 | nM | 7.89 | Inhibition of rat plasma DPP4 | 19275964 |
| Dipeptidyl peptidase 4 | IC50 | = | 12.9 | nM | 7.89 | Inhibition of dipeptidyl peptidase 4 (unknown origin) | - |
| Dipeptidyl peptidase 2 | IC50 | = | 3300.0 | nM | 5.48 | Inhibition of human recombinant DPP2 | 19275964 |
| Dipeptidyl peptidase 9 | IC50 | = | 5980.0 | nM | 5.22 | Inhibition of human DPP9 | 19275964 |
| Dipeptidyl peptidase 8 | IC50 | = | 7000.0 | nM | 5.16 | Inhibition of human recombinant DPP8 | 19275964 |
| Prolyl endopeptidase FAP | IC50 | = | 10300.0 | nM | 4.99 | Inhibition of human FAP expressed in african green monkey COS1 cells | 19275964 |
Literature References
Data from ChEMBL 36 via Core Engine